Oxyg'App vs ESPA 2025
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
Oxyg'App
Read full descriptionHide full description
Oxygen management should rely on oxygenation targets, with minimal and maximal boundaries to avoid both hypoxemia and hyperoxemia. Oxygen titration using targets based on arterial saturation (SaO2) are not feasible due to discontinuous measurements of this parameter that requires an arterial blood gas analysis. The oxygen support must be titrated based on SpO2 that allows continuous measurements of patient oxygenation, even though this technology has limitations and needs improvement. We may hope for a major technological evolution as the main working principles of this technology, which are more than 50 years old, have not changed appreciably. Waiting for this improvement in pulse oximetry technology, clinicians should tread carefully and apply algorithms to correct for these deficiencies. Whatever the clinician thinks is the appropriate oxygenation target, this "optimal SaO2" target needs to be corrected when utilizing the SpO2 for the titration based on skin pigmentation and oximeter brand. It has become increasingly apparent that the SpO2 target cannot simply be the SaO2 target! To facilitate the quest of the optimal SpO2 targets and to promote a more homogeneous management of patientsβ oxygenation regardless of skin pigmentation or monitoring device of oxygenation there are several potential solutions. We believe that one SpO2 target does not fit all patients and that further clinical trials and clinical guidelines should use corrected SpO2 targets rather than universal targets for all patients. Consequently, clinicians should first define a SaO2 target relative to the patient under respiratory support and then apply corrections for the mean bias related to the skin pigmentation and to the oximeter used to get the corrected SpO2.
ESPA 2025
Read full descriptionHide full description
Your personal guide to the 15th European congress for Paediatric Anaesthesiology in Berlin. You will be informed in time about everything important before and during the conference. Full conference programme, detailed information, personal programme, your personal QR ticket, possibility to ask live questions to the speakers, possibility to view e-posters and abstracts, the ability to communicate with colleagues through networking - all simply in your pocket.
Screenshots
Verdict
Oxyg'App and ESPA 2025 are too close to call on the numbers: across 5 compared parameters β price, ads, in-app purchases and device support among them β neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | Oxyg'App | ESPA 2025 |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 6 days | β |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPod | iPhone, iPod |
| Requires iOS | 13.0 | 12.0 β better |
| Further details β not scored | ||
| Size | 32 MB | 40 MB |
| Age rating | 4+ | 17+ |
| Developer | L'Institut universitaire de cardiologie et de pneumologie de QuΓ©bec (IUCPQ) | T.R.I., s.r.o. |
In-app purchases
Oxyg'App
No in-app purchases
ESPA 2025
No in-app purchases









